These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 21108438

  • 1. Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease.
    Pai V, Porter K, Ranalli M.
    Pediatr Blood Cancer; 2011 Jan; 56(1):45-9. PubMed ID: 21108438
    [Abstract] [Full Text] [Related]

  • 2. Octreotide in the management of diarrhea induced by graft versus host disease.
    Ippoliti C, Neumann J.
    Oncol Nurs Forum; 1998 Jun; 25(5):873-8. PubMed ID: 9644703
    [Abstract] [Full Text] [Related]

  • 3. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
    Rosenoff SH, Gabrail NY, Conklin R, Hohneker JA, Berg WJ, Warsi G, Maloney J, Benedetto JJ, Miles EA, Zhu W, Anthony L.
    J Support Oncol; 2006 Jun; 4(6):289-94. PubMed ID: 16805331
    [Abstract] [Full Text] [Related]

  • 4. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH.
    Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Topkan E, Karaoglu A.
    Oncology; 2006 Sep; 71(5-6):354-60. PubMed ID: 17873499
    [Abstract] [Full Text] [Related]

  • 10. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
    Rosenoff S.
    Support Care Cancer; 2004 Aug; 12(8):561-70. PubMed ID: 15160318
    [Abstract] [Full Text] [Related]

  • 11. Octreotide in chemotherapy induced diarrhoea in colorectal cancer: a review article.
    Bhattacharya S, Vijayasekar C, Worlding J, Mathew G.
    Acta Gastroenterol Belg; 2009 Aug; 72(3):289-95. PubMed ID: 19902860
    [Abstract] [Full Text] [Related]

  • 12. Octreotide Acetate in the Treatment of Fluorouracil-Induced Diarrhea.
    Goumas P, Naxakis S, Christopoulou A, Chrysanthopoulos C, Nikolopoulou V, Kalofonos HP.
    Oncologist; 1998 Aug; 3(1):50-53. PubMed ID: 10388084
    [Abstract] [Full Text] [Related]

  • 13. Management of cancer treatment-related diarrhea. Issues and therapeutic strategies.
    Kornblau S, Benson AB, Catalano R, Champlin RE, Engelking C, Field M, Ippoliti C, Lazarus HM, Mitchell E, Rubin J, Stiff PJ, Vokes E, Wadler S.
    J Pain Symptom Manage; 2000 Feb; 19(2):118-29. PubMed ID: 10699539
    [Abstract] [Full Text] [Related]

  • 14. Phase I trial of the somatostatin analog octreotide acetate in the treatment of fluoropyrimidine-induced diarrhea.
    Wadler S, Haynes H, Wiernik PH.
    J Clin Oncol; 1995 Jan; 13(1):222-6. PubMed ID: 7799023
    [Abstract] [Full Text] [Related]

  • 15. Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.
    Mystakidou K, Katsouda E, Tsilika E, Smyrniotis V, Vassiliou I, Tsiatas M, Vlahos L.
    Anticancer Res; 2006 Jan; 26(3B):2325-8. PubMed ID: 16821610
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recommended guidelines for the treatment of chemotherapy-induced diarrhea.
    Wadler S, Benson AB, Engelking C, Catalano R, Field M, Kornblau SM, Mitchell E, Rubin J, Trotta P, Vokes E.
    J Clin Oncol; 1998 Sep; 16(9):3169-78. PubMed ID: 9738589
    [Abstract] [Full Text] [Related]

  • 18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 19. Clinical implications of chemotherapy-induced diarrhea in patients with cancer.
    Arnold RJ, Gabrail N, Raut M, Kim R, Sung JC, Zhou Y.
    J Support Oncol; 2005 May; 3(3):227-32. PubMed ID: 15915825
    [Abstract] [Full Text] [Related]

  • 20. Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease.
    Ely P, Dunitz J, Rogosheske J, Weisdorf D.
    Am J Med; 1991 Jun; 90(6):707-10. PubMed ID: 2042686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.